What Causes Psoriasis? A Research-Based Guide to Every Root Cause and Trigger

Psoriasis affects over 125 million people worldwide — yet a surprising number of those living with it do not know why they have it. The answer is not simple, but it is knowable. Understanding the causes of psoriasis is the first step toward managing it more effectively and breaking the cycle of flares.

This guide covers every established and emerging cause of psoriasis — from the genetic code you were born with to the daily habits and environmental forces that switch the disease on and off. It draws on peer-reviewed research published in leading dermatology journals and is written to be genuinely useful for patients, not just technically accurate.

The Short Answer: What Causes Psoriasis?

Psoriasis is caused by a malfunction of the immune system. Specifically, immune cells called T-lymphocytes (T-cells) become overactivated and mistakenly attack healthy skin cells, triggering an inflammatory response that causes new skin cells to form in days instead of the normal 3–4 weeks.

The result is the rapid accumulation of skin cells on the surface — forming the raised, scaly plaques that define the condition. But this immune dysfunction does not happen in isolation; it is the product of a combination of genetic predisposition, immune system abnormalities, and environmental or lifestyle triggers working together.

The three-part model of psoriasis causation: 1. Genetic predisposition — inherited risk encoded in your DNA 2. Immune system dysfunction — the mechanism that drives skin inflammation 3. Environmental and lifestyle triggers — the factors that switch the disease on All three elements typically need to be present for psoriasis to develop.

Genetic Causes: The Foundation of Psoriasis Risk

Psoriasis is one of the most genetically influenced skin conditions known to medicine. Large-scale genome-wide association studies (GWAS) have now identified more than 80 genomic loci associated with psoriasis susceptibility — a level of genetic complexity that explains why the condition behaves differently in different people, and why it runs so strongly in families.

The PSORS1 Gene Region

The most significant genetic risk factor for psoriasis lies in the PSORS1 (Psoriasis Susceptibility 1) region on chromosome 6p21. This region contains the HLA-Cw6 allele — a variant of the human leukocyte antigen gene that is present in approximately 60–65% of people with early-onset psoriasis, compared to around 15% of the general population. HLA-Cw6 affects how the immune system identifies and responds to protein fragments, making those who carry it more prone to the immune misidentification of skin cells that drives psoriasis.

Carrying HLA-Cw6 is not a guarantee of developing psoriasis — it is a risk factor, not a destiny. What it means practically is that the immune threshold for triggering a psoriasis response is lower, making it easier for environmental or lifestyle factors to set the condition in motion.

Family History and Inheritance Patterns

The hereditary nature of psoriasis is well-established. If one parent has psoriasis, a child faces approximately a 10% chance of developing the condition. If both parents are affected, that risk rises to between 40% and 70%. Studies of identical twins show a concordance rate of around 35–70%, confirming that while genetics is the foundation, it is not the complete story — the environment must also play a role.

Psoriasis does not follow a simple dominant or recessive inheritance pattern. Instead, it is polygenic — influenced by many genes each contributing a small effect — and multifactorial, meaning non-genetic factors are also required. This is why psoriasis can skip generations, appear in one identical twin and not the other, and present very differently even within the same family.

Genetic Variants Beyond PSORS1

Beyond PSORS1, research has identified genetic variants in genes related to IL-23 signalling (IL23R, IL12B), TNF-alpha production (TNFAIP3, TNIP1), and skin barrier function (LCE3B, LCE3C). The IL-23 pathway variants are particularly significant — they partly explain why biologics targeting IL-17 and IL-23 are so effective in psoriasis, since those pathways are genetically amplified in affected individuals.

Immune System Dysfunction: The Engine of Psoriasis

Even in people with a genetic predisposition, psoriasis requires an immune trigger to manifest. Understanding the immune mechanism clarifies not just why psoriasis happens, but why so many different triggers — from stress to strep throat — can produce the same result.

The Role of T-Lymphocytes

In healthy skin, T-lymphocytes circulate as defenders — identifying and neutralising genuine threats like bacteria, viruses, and damaged cells. In psoriasis, a subset of T-cells called Th17 and Th1 cells are chronically overactivated. They misidentify normal skin proteins (particularly keratin proteins in keratinocytes) as threats and launch a sustained inflammatory assault against them.

This is the definition of autoimmunity: the immune system attacking the body it is supposed to protect. The overactivated T-cells release pro-inflammatory signalling molecules — cytokines — that recruit more immune cells to the skin and tell the skin cells to divide rapidly, producing the epidermal hyperproliferation characteristic of psoriasis.

Key Cytokines Driving Psoriasis

Three cytokines are central to the psoriasis inflammatory cascade, and they are worth knowing by name because they are the direct targets of modern biologic therapies:

•       TNF-alpha (Tumour Necrosis Factor-alpha): amplifies inflammation and drives skin cell proliferation

•       IL-17 (Interleukin-17): produced primarily by Th17 cells; strongly promotes neutrophil recruitment and epidermal hyperplasia

•       IL-23 (Interleukin-23): acts upstream of IL-17; maintains Th17 cell survival and amplifies the entire inflammatory response

The discovery of these cytokines' roles in psoriasis transformed dermatology. Biologic drugs that target TNF-alpha, IL-17, and IL-23 have produced levels of skin clearance that were previously unimaginable with conventional treatments.

Dendritic Cells: The Initiators

Before T-cells become overactivated, dendritic cells — the immune system's 'scouts' — play a critical initiating role. In people with psoriasis, plasmacytoid and myeloid dendritic cells in the skin produce excessive amounts of interferon-alpha and IL-12, which prime the T-cell response. Identifying what initially activates these dendritic cells (injury, infection, stress hormones) is the subject of ongoing research.

Environmental and Lifestyle Triggers: What Switches Psoriasis On

Genetic predisposition creates the biological setting for psoriasis. Environmental and lifestyle triggers are what convert that potential into an active disease. For many patients, understanding and managing their personal triggers is where they have the most practical power over their condition.

Psychological Stress

Stress is the most consistently reported psoriasis trigger across studies and patient surveys worldwide. Psychological stress activates the hypothalamic-pituitary-adrenal (HPA) axis, elevating cortisol and catecholamines (adrenaline, noradrenaline) in the bloodstream. These stress hormones directly alter immune function — suppressing regulatory T-cells that normally keep inflammatory responses in check, while promoting the Th17 pathway central to psoriasis.

A particularly important study by Verhoeven et al. (2009) found that patients who identified as 'stress responders' had significantly more psoriasis activity and worse quality of life outcomes than those who did not identify stress as a trigger. Stress management — whether through yoga, mindfulness, counselling, or cognitive behavioural therapy — is therefore not a soft supplement to psoriasis treatment; it is a core part of it.

Skin Injury: The Koebner Phenomenon

Any physical trauma to healthy skin — cuts, burns, surgical incisions, vaccinations, friction, insect bites, or even sunburn — can trigger new psoriasis plaques at the site of injury in a susceptible individual. This is known as the Koebner phenomenon (or isomorphic response), first described by German dermatologist Heinrich Koebner in 1876.

The Koebner response occurs in approximately 25% of people with psoriasis and is more likely during periods of active disease. The mechanism involves disruption of the skin barrier, which activates local immune responses — including dendritic cell activation and T-cell recruitment — at the injury site. Tattoos, piercings, and even aggressive scratching of existing plaques can trigger the Koebner response.

Infections

Infections are one of the most clearly documented environmental causes of psoriasis onset and flare. Group A streptococcal infections — particularly streptococcal pharyngitis (strep throat) and perianal streptococcal dermatitis — are the most well-established infectious triggers, particularly for guttate psoriasis in children and young adults. The mechanism involves molecular mimicry: streptococcal proteins share structural similarities with skin proteins, causing immune cells primed against the bacteria to cross-react with keratinocytes.

Other infections associated with psoriasis flares include Staphylococcus aureus skin infections, HIV (which causes a paradoxical and often severe worsening of psoriasis), Candida infections, and dental infections. Treating the underlying infection promptly can significantly reduce psoriasis activity.

Medications That Cause or Worsen Psoriasis

A number of commonly prescribed medications are well-documented causes of psoriasis onset or worsening. Clinicians initiating these medications in patients with a personal or family history of psoriasis should counsel patients about this risk:

•       Lithium carbonate (used in bipolar disorder) — strongly associated with psoriasis induction and worsening

•       Beta-blockers (propranolol, atenolol) — implicated in new-onset and worsening psoriasis

•       Anti-malarial drugs (chloroquine, hydroxychloroquine) — can precipitate erythrodermic or pustular flares

•       NSAIDs (indomethacin in particular) — associated with psoriasis worsening in some patients

•       Oral corticosteroids — can cause severe rebound psoriasis flares upon discontinuation

•       ACE inhibitors and interferons — less common but documented triggers

The most clinically significant drug-related cause of severe psoriasis flares is abrupt discontinuation of systemic corticosteroids. This causes a rebound effect — a generalised flare, often pustular, that is dramatically worse than the original presentation. For this reason, dermatologists avoid long-term oral steroids for psoriasis management.

Alcohol Consumption

Alcohol has a complex and well-documented relationship with psoriasis. Epidemiological studies consistently show higher rates of alcohol consumption in psoriasis patients, and numerous studies have found that heavy alcohol use is associated with more severe psoriasis, poorer treatment response, and higher rates of comorbid conditions. The mechanisms are multiple: alcohol promotes systemic inflammation via lipopolysaccharide (LPS) translocation from the gut, suppresses regulatory T-cell function, directly activates keratinocyte proliferation, and is hepatotoxic - which matters because several psoriasis systemic treatments (particularly methotrexate) are also processed by the liver.

Reducing or eliminating alcohol consumption is one of the highest-impact lifestyle modifications a person with psoriasis can make. It is not merely about avoiding a trigger — it actively removes a driver of systemic inflammation that underlies the entire disease process.

Tobacco Smoking

The relationship between smoking and psoriasis is strong, consistent, and dose-dependent. Meta-analyses have found that current smokers have approximately double the risk of developing psoriasis compared to non-smokers, and that the risk increases with daily cigarette consumption. Smoking is particularly strongly linked to palmoplantar pustulosis — a form of psoriasis affecting the palms and soles — to the extent that many researchers consider smoking a necessary cofactor for this subtype.

The mechanisms by which smoking promotes psoriasis include oxidative stress (which activates NF-kB, a key pro-inflammatory transcription factor), nicotine-induced T-cell dysregulation, skin barrier disruption, and vasoconstriction that reduces skin oxygenation. Quitting smoking is associated with significant improvement in psoriasis symptoms over time.

Diet and Gut Health

Diet influences psoriasis through multiple pathways — primarily via its effects on systemic inflammation, gut microbiome composition, and metabolic health. Western-style diets high in refined carbohydrates, saturated fats, red meat, and alcohol are consistently associated with more severe psoriasis and higher rates of metabolic comorbidities. Conversely, Mediterranean-style anti-inflammatory diets are associated with lower disease activity and improved quality of life outcomes.

The gut microbiome — the vast community of bacteria, fungi, and other microorganisms inhabiting the intestine — has emerged as a significant player in psoriasis pathogenesis. Multiple studies have identified reduced microbial diversity and altered microbial composition (dysbiosis) in people with psoriasis, with reductions in beneficial bacteria, including Faecalibacterium prausnitzii and Akkermansia muciniphila, being particularly consistent findings. These bacteria play key roles in maintaining gut barrier integrity and regulating systemic immune responses, including the Th17/Treg balance central to psoriasis.

Hormonal Changes

Hormonal fluctuations influence psoriasis activity throughout life, and are particularly relevant for women. The postpartum period (after childbirth) is a well-recognised high-risk time for psoriasis flares, as the protective hormonal environment of pregnancy withdraws rapidly. Puberty, when sex hormone levels shift dramatically, is also a common time for psoriasis onset — consistent with the peak age of first diagnosis in the 15–30 age range.

Interestingly, many women experience improvement in psoriasis during pregnancy — particularly in the second and third trimester — attributed to the natural shift toward a Th2-dominant immune profile (which suppresses the Th1 and Th17 responses central to psoriasis). Menopause, with its oestrogen decline and associated increase in systemic inflammation, is often associated with worsened psoriasis. These hormonal links also connect psoriasis to metabolic syndrome, where disrupted sex hormone balance is a contributing factor.

Obesity and Metabolic Factors

Obesity is both a cause and a consequence of psoriasis through complex bidirectional mechanisms. Adipose (fat) tissue is metabolically active — it produces pro-inflammatory cytokines (adipokines) including leptin, resistin, and TNF-alpha, which directly amplify the inflammatory pathways driving psoriasis. Large epidemiological studies have found that higher body mass index (BMI) is associated with increased psoriasis risk, greater disease severity, and poorer response to treatment.

The relationship goes both ways: psoriasis patients are more likely to develop obesity, partly due to physical activity limitation from painful skin, partly from treatment-related side effects, and partly from shared inflammatory mechanisms with metabolic syndrome. Weight loss in overweight and obese psoriasis patients has been shown in clinical trials to significantly improve disease activity, including in patients on systemic therapy - with some studies showing that weight loss alone can produce PASI improvements comparable to adding a second medication.

Climate and Seasonality

Cold, dry weather consistently worsens psoriasis for the majority of patients — and this pattern is particularly relevant for patients in northern and central India, where winters can be cold and dry. The combination of reduced ultraviolet light exposure (which has natural anti-inflammatory properties on the skin), lower humidity that compromises the skin barrier, and cold-induced vasoconstriction creates conditions highly favourable to psoriasis flares. Heating systems further reduce indoor humidity, compounding the drying effect on skin.

Conversely, warm, humid climates — and particularly moderate sun exposure — tend to improve psoriasis for most (though not all) patients. This is the biological basis for phototherapy as a treatment, and for the improvement many psoriasis patients experience when moving to tropical or coastal environments.

Emerging Causes: What the Latest Research Is Finding

The Skin Microbiome

Separate from the gut microbiome, the skin microbiome — the community of microorganisms living on the skin surface — is disrupted in psoriasis. Studies comparing psoriatic plaques to non-lesional skin and healthy control skin have found reduced microbial diversity, increased Staphylococcus aureus colonisation, and reduced beneficial Cutibacterium acnes on affected skin. Whether these changes are a cause or consequence of psoriasis inflammation is an active area of research, but there is growing interest in microbiome-targeted interventions as adjunct treatments.

The Exposome: Cumulative Environmental Exposures

The concept of the 'exposome' — the totality of environmental exposures across a lifetime — is gaining traction in psoriasis research. Air pollution (particularly particulate matter PM2.5), occupational exposures (solvents, metals, detergents), childhood infections, antibiotic use (which disrupts both gut and skin microbiomes), and even early-life stress all appear to modulate psoriasis risk. A 2022 analysis in the British Journal of Dermatology found that areas with higher air pollution indices had significantly higher psoriasis prevalence rates, independent of other socioeconomic factors.

Epigenetic Modifications

Epigenetics — changes in gene expression that do not alter the underlying DNA sequence — are emerging as an important bridge between environmental exposures and psoriasis risk. Methylation patterns in key immune and inflammatory genes are altered in psoriasis patients compared to healthy controls. Crucially, some of these epigenetic changes appear to be reversible — potentially explaining why lifestyle interventions like smoking cessation, weight loss, and dietary changes have measurable effects on disease severity even in patients with strong genetic predisposition.

What Does NOT Cause Psoriasis

Clearing up misconceptions is as important as explaining actual causes — particularly in India, where psoriasis-related stigma still drives social discrimination.

Psoriasis is NOT caused by: • Poor hygiene or dirty skin • Contagion — it cannot spread from person to person • A bad diet alone (though diet can worsen or improve existing psoriasis) • Spiritual or moral failing (a harmful belief still held in some communities) • Allergies — though some people with psoriasis also have allergies, they are separate conditions. Psoriasis IS caused by: genetics + immune dysfunction + environmental triggers working together.

Stigma based on these misconceptions causes real harm — driving delayed care-seeking, social isolation, depression, and relationship difficulties. Sharing accurate information with family members and community networks is one of the most impactful things a person with psoriasis can do beyond managing their own condition.

How Causes Determine Treatment: Connecting the Science to Your Care

Understanding what causes psoriasis is not merely academic — it directly informs treatment decisions. If stress is a primary trigger, stress management is not optional. If alcohol is worsening your psoriasis, no medication will fully compensate for continuing to drink. If your gut microbiome is disrupted, dietary and probiotic interventions deserve a place in your management plan alongside topical treatments.

The most effective psoriasis management strategies work across multiple levels simultaneously — addressing the immune mechanism through appropriate medications, reducing trigger exposure through lifestyle changes, and supporting systemic health through diet, sleep, and exercise. This is the logic behind the integrative approach that combines modern dermatological care with evidence-backed Ayurvedic principles.

Conclusion: Psoriasis Has a Cause — and That Cause Is Manageable

Psoriasis is not random, and it is not your fault. It arises from a specific convergence of genetic vulnerability, immune system dysregulation, and environmental pressures that — once understood — gives you real leverage over the condition. You cannot rewrite your DNA, but you can manage stress, adjust your diet, quit smoking, moderate alcohol, protect your skin, and choose treatments that work with your biology rather than against it.

The science of psoriasis causation has never been clearer, and it points consistently toward the same conclusion: the most effective management addresses the whole person — skin, immune system, gut, mind, and lifestyle — not just the visible plaques. Whether you are newly diagnosed or have been living with psoriasis for years, understanding its causes is the most powerful tool you have.

Frequently Asked Questions: Causes of Psoriasis

Q1. Is psoriasis caused by a virus or bacteria?

No — psoriasis is not caused by a virus or bacteria. It is an autoimmune condition driven by the body's own immune system. However, certain bacterial infections (particularly streptococcal throat infections) can act as triggers that set off a psoriasis flare in someone who is already genetically predisposed to the condition.

Q2. Can psoriasis be caused by stress alone?

Stress alone is unlikely to cause psoriasis from scratch in someone with no genetic predisposition. However, in people who carry psoriasis-associated genes, psychological stress is one of the most potent triggers for initial onset and subsequent flares. Multiple studies have confirmed that stress activates the same immune pathways that drive psoriasis inflammation.

Q3. Is psoriasis hereditary?

Yes, psoriasis has a significant genetic component. If one parent has psoriasis, a child has approximately a 10% chance of developing it; if both parents are affected, the risk rises to 40–70%. However, genetics alone is not sufficient — environmental triggers are also required, which is why psoriasis can skip generations and appear differently within the same family.

Q4. Can food cause psoriasis?

Food alone does not cause psoriasis in someone without a genetic predisposition. However, for people who already have psoriasis, certain dietary patterns — particularly those high in alcohol, processed foods, red meat, and refined sugar — are associated with worsening disease severity. Anti-inflammatory diets rich in omega-3 fatty acids and fresh vegetables are associated with improved outcomes.

Q5. Why did I suddenly get psoriasis with no family history?

Psoriasis can appear with no obvious family history for several reasons. First, it is polygenic — involving many genes each with small effects — so the genetic risk may be distributed across many relatives without any single family member having an obvious case. Second, family members may have undiagnosed or mild psoriasis. Third, environmental factors (a new medication, a significant infection, severe stress, a major life change) may have tipped the balance in someone who had always carried subclinical genetic risk.

Q6. Does psoriasis get worse with age?

Psoriasis does not inevitably worsen with age, but its course is unpredictable and highly individual. Many patients experience periods of worsening and remission throughout their lives. Cumulative lifestyle factors — weight gain, alcohol consumption, smoking, chronic stress — often worsen psoriasis over time if not managed. Conversely, people who actively manage triggers often find their disease becomes more stable and controllable as they age.

Q7. Can weight gain cause psoriasis?

Obesity does not directly cause psoriasis, but it significantly increases risk and severity. Adipose (fat) tissue produces pro-inflammatory cytokines — including TNF-alpha — that amplify the same inflammatory pathways that drive psoriasis plaques. Studies have found a dose-dependent relationship between BMI and psoriasis risk. Importantly, weight loss in obese psoriasis patients produces clinically meaningful improvements in disease severity.

Q8. Can a gut infection or antibiotic use cause psoriasis?

There is growing evidence that gut microbiome disruption — caused by infections, antibiotic courses, or poor diet — can contribute to psoriasis onset or worsening. Antibiotics can significantly reduce gut microbial diversity, altering immune regulation in ways that promote inflammatory conditions, including psoriasis. This does not mean antibiotics should be avoided when medically necessary, but it underscores the importance of gut health in psoriasis management.

Q9. Why do some medications cause psoriasis?

Certain medications interfere directly with the immune regulatory pathways that normally keep psoriasis in check. Lithium, for example, promotes keratinocyte proliferation. Beta-blockers alter the balance between immune cell populations. Oral corticosteroids, when discontinued abruptly, allow inflammatory pathways that were suppressed to 'rebound' powerfully, often causing severe psoriasis flares. Patients starting any new medication should mention their psoriasis history to their prescribing doctor.

Q10. Can I prevent psoriasis if it runs in my family?

You cannot change your genes, but you can significantly modify your risk. Maintaining a healthy weight, not smoking, limiting alcohol, managing stress through regular exercise and mindfulness, following an anti-inflammatory diet, protecting your skin from injury, and treating infections promptly are all evidence-backed strategies that reduce the likelihood of psoriasis onset — or the frequency and severity of flares if psoriasis has already developed.

Sources and References

•       Boehncke WH, Schön MP. Psoriasis. Lancet. 2015;386(9997):983–994.

•       Capon F. The genetic basis of psoriasis. Int J Mol Sci. 2017;18(12):2526.

•       Duffin KC, et al. The genetics of psoriasis and psoriatic arthritis. Dermatol Clin. 2015;33(1):1–11.

•       Lowes MA, Suárez-Fariñas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32:227–255.

•       Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JNWN. Psoriasis. Lancet. 2021;397(10281):1301–1315.

•       Verhoeven EWM, et al. Stress and the relapse of psoriasis: results of a prospective study. Br J Dermatol. 2009;160(4):730–736.

•       Naldi L, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis. J Invest Dermatol. 2005;125(1):61–67.

•       Brenaut E, et al. Alcohol consumption and psoriasis: epidemiological and pathophysiological links. Eur J Dermatol. 2013;23(6):789–798.

•       Scher JU, Abramson SB. The microbiome and psoriatic disease. J Invest Dermatol. 2011;131(12):2442–2444.

•       Sánchez-Carazo JL, et al. Comorbidities and health-related quality of life in Spanish patients with moderate to severe psoriasis. J Eur Acad Dermatol Venereol. 2014;28(7):906–914.

•       Dogra S, Mahajan R. Psoriasis: Epidemiology, clinical features, co-morbidities. Indian Dermatol Online J. 2016;7(6):471–480.

•       Kim WB, et al. Diagnosis and management of psoriasis. Can Fam Physician. 2017;63(4):278–285.

•       Takeshita J, et al. Psoriasis and comorbid diseases. J Am Acad Dermatol. 2017;76(3):393–403.

•       Ahn CS, Huang WW. Psoriasis diagnosis and management. Med Clin North Am. 2015;99(6):1281–1292.

•       Parisi R, et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377–385.

•       Basavaraj KH, et al. Diet in dermatology: present perspectives. Indian J Dermatol. 2010;55(3):205–210.

•       Budu-Aggrey A, et al. Evidence of a causal relationship between body mass index and psoriasis. PLOS Med. 2019;16(1):e1002739.

•       National Psoriasis Foundation. Triggers. www.psoriasis.org (accessed 2024).

•       IADVL Psoriasis Task Force. Indian guidelines for the management of psoriasis. Indian J Dermatol Venereol Leprol. 2020.

Last reviewed: June 2026. This article is for informational purposes only and does not substitute medical advice. Consult a qualified dermatologist for diagnosis and personalised care.